![Oliver von Stein](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Oliver von Stein
Chief Executive Officer at
Berlin Cures Holding AG
Profile
Oliver von Stein currently works at Berlin Cures Holding AG, as Chief Executive Officer & Director from 2024 and Berlin Cures GmbH, as Chief Executive Officer.
Dr. von Stein also formerly worked at Silence Therapeutics Plc, as Operations Director from 2014 to 2015, MediGene AG, as Project Leader, and Flerie AB, as Chief Scientific Officer.
Dr. von Stein received his doctorate degree from Karlsruher Institut für Technologie.
Oliver von Stein active positions
| Companies | Position | Start |
|---|---|---|
Berlin Cures Holding AG
 Berlin Cures Holding AG BiotechnologyHealth Technology Manufactures autoantibodies | Chief Executive Officer | 15/06/2023 |
Berlin Cures GmbH
 Berlin Cures GmbH Pharmaceuticals: MajorHealth Technology Develops drug to neutralize auto antibodies | Chief Executive Officer | - |
Former positions of Oliver von Stein
| Companies | Position | End |
|---|---|---|
| SILENCE THERAPEUTICS PLC | Chief Operating Officer | 01/08/2015 |
| MEDIGENE AG | Corporate Officer/Principal | - |
| FLERIE INVEST AB | Chief Tech/Sci/R&D Officer | - |
Education of Oliver von Stein
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
7
1st degree connections
6
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 6 |
|---|---|
MediGene AG
 MediGene AG BiotechnologyHealth Technology Engages in the clinical research and development of novel drugs against cancer & autoimmune diseases with focus on personalized immunotherapies | Health Technology |
Silence Therapeutics Plc
 Silence Therapeutics Plc Miscellaneous Commercial ServicesCommercial Services Engages in the research and development of novel pharmaceutical products | Commercial Services |
Flerie AB
 Flerie AB Pharmaceuticals: MajorHealth Technology Discovers and develops drugs for the treatment of inflammation and cancer diseases | Health Technology |
Karlsruher Institut für Technologie
 Karlsruher Institut für Technologie Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Berlin Cures GmbH
Berlin Cures GmbH Pharmaceuticals: MajorHealth Technology Develops drug to neutralize auto antibodies | Health Technology |
Berlin Cures Holding AG
Berlin Cures Holding AG BiotechnologyHealth Technology Manufactures autoantibodies | Health Technology |
- Stock Market
- Insiders
- Oliver von Stein
